NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.
NACDS announced that former U.S. Senator and six-term Congressman Jeff Flake (R-AZ) will speak at the April 29 NACDS Political Action Committee (NACDS-PAC) Breakfast during the 2019 NACDS Annual Meeting, which will be held April 27-30, in Palm Beach, Fla.
Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”
An impressive force of 424 advocates from all 50 states reached every Congressional office during the 2019 NACDS RxIMPACT Day on Capitol Hill.
NACDS today announced that former Speaker of the U.S. House of Representatives Paul Ryan (R-WI) will speak during the Tuesday, April 30, Business Program at the 2019 NACDS Annual Meeting, which will be held April 27-30, in Palm Beach, Fla.
NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”
NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.
NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.
NACDS today welcomed the White House’s release of the 2019 National Drug Control Strategy, and expressed in particular the Association’s commitment to collaboration as part of the solution to the opioid-abuse epidemic.
Rebecca Bubel, RPh, 2019 NACDS Regional Chain Conference chair and senior director of store operations, Kinney Drugs, Inc.
The National Association of Chain Drug Stores’ (NACDS) campaign-style approach to the issues crucial for pharmacy value and viability dominated today’s opening session of the 2019 NACDS Regional Chain Conference.
NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the Association’s “Access Agenda” – which emphasizes that pharmacies provide access to health policy solutions, just as they provide access to vital health services every day in neighborhoods across the nation.
Mark Panzer, NACDS Chairman of the Board and senior vice president, pharmacy and health & wellness, Albertsons Companies, said, “NACDS talks about our Access Agenda, and its three parts: offense, defense, and addressing the wellbeing of our communities. On offense, we are enhancing access to newer services. When we talk about defense, we are talking about preserving patients’ access to care. And that means DIR fee reform. The third area – working as partners for stronger and safer communities – includes helping to solve opioid abuse. This remains an important issue, where we have seen progress and where we remain committed.”
“Across all of our NACDS issues and services, here is the message that I want to give to you today, and it’s from my view as the NACDS chairman and as an industry veteran. NACDS has never been better equipped to deliver the value that we as members expect, and need – even on the toughest of issues.”
NACDS President and CEO Steven C. Anderson, IOM, CAE, led an interactive discussion including members of the NACDS senior staff regarding advocacy on DIR fee reform, broader reimbursement issues, opioid-abuse prevention and expanding pharmacy’s scope of business.
“What we are not doing is just ‘working the issues,’” Anderson stated. “What we are doing is waging campaigns – tough campaigns. Working the issues is waiting for things to happen. Waging campaigns is making things happen, and doing so with everything we have – consistently, creatively, aggressively, passionately, cohesively, and as a modern political and advocacy organization.”
In the pursuit of DIR fee reform and other ways to help [ READ MORE ]
